Dynamic Technology Lab Private Ltd Invests $760,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Dynamic Technology Lab Private Ltd purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 10,983 shares of the company's stock, valued at approximately $760,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geode Capital Management LLC increased its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after buying an additional 14,876 shares during the period. Norges Bank acquired a new stake in shares of Henry Schein in the fourth quarter worth $103,301,000. Charles Schwab Investment Management Inc. increased its stake in shares of Henry Schein by 1.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock worth $82,464,000 after acquiring an additional 16,616 shares during the period. ING Groep NV raised its holdings in shares of Henry Schein by 34.1% during the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company's stock worth $80,486,000 after purchasing an additional 295,785 shares during the last quarter. Finally, National Bank of Canada FI lifted its position in Henry Schein by 102.4% during the fourth quarter. National Bank of Canada FI now owns 1,084,511 shares of the company's stock valued at $75,048,000 after purchasing an additional 548,561 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on HSIC. StockNews.com upgraded Henry Schein from a "hold" rating to a "buy" rating in a research note on Wednesday. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Finally, UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Five equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $0.10 during midday trading on Friday, hitting $63.66. The company's stock had a trading volume of 336,796 shares, compared to its average volume of 1,601,298. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business's 50 day simple moving average is $72.23 and its 200 day simple moving average is $72.27. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a market cap of $7.91 billion, a P/E ratio of 26.06, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.66 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.